熱門資訊> 正文
Telesis Bio报告第一季度业绩
2024-05-10 19:28
- Telesis Bio press release (NASDAQ:TBIO): Q1 revenue was $3.4 million compared to $6.3 million for the three months ended March 31, 2023.
- Net loss per share was $5.52
More on Telesis Bio
- Telesis Bio announces leadership transition amid new commercial focus
- Seeking Alpha’s Quant Rating on Telesis Bio
- Historical earnings data for Telesis Bio
- Financial information for Telesis Bio
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。